Viewing Study NCT06161051


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-08 @ 7:24 PM
Study NCT ID: NCT06161051
Status: COMPLETED
Last Update Posted: 2023-12-07
First Post: 2023-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None aNSCLC View